Papilledema Due to Mirtazapine
| Autor: | Mehmet Emin Ceylan, Alper Evrensel, Gökçe Cömert |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: | |
| Zdroj: | Balkan Medical Journal, Vol 33, Iss 3, Pp 363-365 (2016) |
| Druh dokumentu: | article |
| ISSN: | 2146-3123 2146-3131 86871609 |
| DOI: | 10.5152/balkanmedj.2016.150151 |
| Popis: | Background: Mirtazapine is a tetracyclic antidepressant that enhances both noradrenergic and serotonergic transmission. The most common cause of papilledema is increased intracranial pressure due to brain tumor. Also it may occur as a result of idiopathic intracranial hypertension (IIH, pseudo tumor cerebri). Moreover, papilledema may also develop due to retinitis, vasculitis, Graves’ disease, hypertension, leukemia, lymphoma, diabetes mellitus and radiation. Case Report: In this article, a patient who developed papilledema while under treatment with mirtazapine (30 mg/day) for two years and recovered with termination of mirtazapine treatment was discussed to draw the attention of clinicians to this side effect of mirtazapine. Conclusion: Idiopathic intracranial hypertension and papilledema due to psychotropic drugs has been reported in the literature. Mirtazapine may rarely cause peripheral edema. However, papilledema due to mirtazapine has not been previously reported. Although papilledema is a very rare side effect of an antidepressant treatment, fundoscopic examinations of patients must be performed regularly. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|